Objective. The aim of this study was to evaluate the influence of a gradual increase in the plasma total cholesterol concentration and of lipid peroxidation on endothelial function in rabbit arteries. Material and methods. Fifty male New Zealand white rabbits were fed a diet enriched with 0.5% cholesterol and 10% coconut oil and were allocated to one of nine groups (G2 to G10) based on sequential determinations of their plasma total cholesterol concentration (each group covered an interval of 100 mg/dL). The control group (G1) consisted of five rabbits fed a non-supplemented diet. The rabbits were killed at the end of the treatment and the total plasma cholesterol concentration, arterial wall cholesterol level and lipid peroxidation based on the quantification of malondialdehyde were determined using commercial kits. Endothelial function was assessed based on concentration-response curves to acetylcholine and sodium nitroprusside in aortic segments. Results: Treatment with a cholesterol-rich diet resulted in disproportional increases in the arterial wall cholesterol concentration, lipid peroxidation and a disproportional decrease in the maximum endothelium-dependent relaxations in relation to the plasma total cholesterol concentration. However, the maximum endothelium-dependent relaxations were proportional to the increase in the arterial wall content of malondialdehyde. Conclusions. These results show that the levels of arterial wall cholesterol, lipid peroxidation and endothelial dysfunction are not proportional to the degree of hypercholesterolemia, although endothelial dysfunction is proportional to the extent of lipid peroxidation in the vessel wall.196293299Beynen, A.C., Katan, M.B., Van Zutphen, L.F.M., Hypo and hyperresponders: Individual differences in the response of serum cholesterol concentration to changes in diet (1987) Adv Lipid Res, 22, pp. 115-171Ludmer, P.L., Selwyn, A.P., Shook, T.L., Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries (1986) N Engl J Med, 315, pp. 1046-1051Lind, L., Lipids and endothelium-dependent vasodilation - a review (2002) Lipids, 37, pp. 1-15Meredith, I.T., Anderson, T.J., Uehata, A., Yeung, A.C., Selwyn, A.P., Ganz, P., Role of endothelium in ischemic coronary syndromes (1993) Am J Cardiol, 72, pp. 27C-31C. , discussion 31C-32CBrown, G., Albers, J.J., Fisher, Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B (1990) N Engl J Med, 323, pp. 1289-1298Pedersen, T.R., Kjekshus, J., Berg, K., Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) (1994) Lancet, 344, pp. 1383-1389Jorge, P.A., Ozaki, M.R., Metze, K., Effects of simvastatin and pravastatin on endothelium-dependent relaxation in hypercholesterolemic rabbits (1994) Exp Toxicol Pathol, 46, pp. 465-469Thakur, N.K., Hayashi, T., Sumi, D., HMG-CoA reductase inhibitor (2001) Am J Physiol Heart Circ Physiol, 281, pp. H75-H83Corti, R., Fuster, V., Fayad, Z., Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: Two years' follow-up by high-resolution noninvasive magnetic resonance imaging (2002) Circulation, 106, pp. 2884-2887Treasure, C.B., Klein, J.L., Weintraub, W.S., Benefical effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease (1995) N Eng J Med, 332, pp. 481-487Jorge, P.A., Ozaki, M.R., De Almeida, E.A., Rapid reversal of endothelial dysfunction in hypercholesterolaemic rabbits treated with simvastatin and pravastatin (1997) Clin Exp Pharmacol Physiol, 24, pp. 948-953Hodis, H.N., Mack, W.J., LaBree, L., Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS) (2002) Circulation, 106, pp. 1453-1459Kita, T., Nagano, Y., Yokode, M., Probucol prevents the progresión of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia (1987) Proc. Natl Acad Sci USA, 84, pp. 5928-5931Paduraru, I., Hurjui, J., Filimon, O., Recent data about the LDL-atherogenesis relationship (2001) Rev Med Chir Soc Med Nat Iasi, 105, pp. 31-36Libby, P., Atherosclerosis: The new view (2002) Sci Am, 286, pp. 46-55Havel, R.J., Elder, H.A., Bragdon, J.H., The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum (1955) J Clin Invest, 34, pp. 1345-1353Naito, H.K., David, J.A., Laboratory considerations: Determination of cholesterol, triglyceride, phospholipid and other lipids in blood and tissues (1984) Lab Res Methods Biol Med, 10, pp. 1-76Buege, J.A., Aust, S.D., Microsomal lipid peroxidation (1978) Methods Enzymol, 52, pp. 302-310Montgomery, D.C., (1991) Design and Analysis of Experiments, , 3rd ed. New York: John Wiley & Sons;Rifai, N., Bachorik, P.S., Albers, J.J., Lipids, lipoproteins and apolipoproteins (1995) Tietz Textbook of Clinical Chemistry, , Burtis CA, Ashwood ER, Tietz NW, editors, 3rd edn. Philadelphia: WB Saunders Company;Rippe, B., Rosegren, B.I., Carlsson, O., Venturoli, D., Transendothelial transport: The vesicle controversy (2002) J Vasc Res, 39, pp. 375-390Pfeffer, M.A., Sacks, F.M., Moye, L.A., Cholesterol and recurrent events: A secondary prevention trial for normolipidemic patients. CARE Investigators (1995) Am J Cardiol, 76, pp. 98C-106CParton, R.G., Caveolae - from ultrastructure to molecular mechanisms (2003) Nat Rev Mol Cell Biol, 4, pp. 162-167Valgimigli, M., Merli, E., Malagutti, P., Endothelial dysfunction in acute and chronic coronary syndromes: Evidence for a pathogenetic role of oxidative stress (2003) Arch Biochem Biophys, 420, pp. 255-261Suaul, P.W., Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis (2003) J Physiol, 547, pp. 21-33Jorge, P.A., Neyra, L.C., Ozaki, M.R., Almeida, E.A., Bragagnolo, N., Effect of eggplant on plasma lipid levels, lipidic peroxidation and reversion of endothelial dysfunction in experimental hypercholesterolemia (1988) Arq Bras Cardiol, 70, pp. 87-91Jorge, P.A., Endothelium, lipids and atherosclerosis (1997) Arq Bras Cardiol, 68, pp. 129-134Downs Jr, Clearfield M, Weis S. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-22Simes, R.J., Marschnner, I.C., Hunt, D., Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: To what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? (2002) Circulation, 105, pp. 1162-1169Shepherd, J., Cobbe, S.M., Ford, I., Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia (1995) West of Scotland Coronary Prevention Study Group. JAMA, 279, pp. 1613-1622